Viewpoint: Will China’s desire to boost food production with biotechnology clash with public wariness of ‘Western’ GM technology?

Credit: IFPRI
Credit: IFPRI

Asia Society Policy Institute has published a paper entitled China’s Genetically Modified Dilemma. This piece, authored by ASPI Australia Research Associate Genevieve Donnellon-May, explores the implications of the Peoples Republic of China’s (PRC) Ministry of Agriculture and Rural Affairs (MARA) decision to approve 27 genetically modified (GM) corn varieties and 14 GM soybean varieties in December of 2023.

“The PRC’s decision to introduce GM seed cultivation and commercialization is part of a broader effort to increase domestic food production and thereby reduce reliance on regional markets,” writes Donnellon-May.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Introducing GMs to increase domestic agricultural output has been met with some opposition from Chinese nationals. “Consumers have long been highly skeptical about eating GM food due to concerns that it causes serious illnesses in humans,” says the report, noting that the “Western roots” of GM crops is one of the reasons for public suspicion. “Having acknowledged the need for better public understanding of biotechnology, Beijing is using state and social media as part of the public relations drive to dispel skepticism.”

[Editor’s note: Read the full report here]

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
ChatGPT-Image-Apr-16-2026-02_56_53-PM
Financial incentives, over diagnosis, and weak oversight: Autism claims are driving up Medicare costs
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
ChatGPT-Image-May-12-2026-11_27_01-AM-2
AI likely to improve health care, research shows—but not for blacks and ethnic minorities
ChatGPT-Image-May-7-2026-01_23_27-PM-2
Viewpoint: Will AI democratize personalized cancer treatment or fuel medical misinformation?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.